Explore BrainMass
Share

Explore BrainMass

    vaccine development

    This content was COPIED from BrainMass.com - View the original, and get the already-completed solution here!

    vaccine development for diseases caused by protists (e.g. malaria, chagas' disease)has been much less successful than for bacterial or viral diseases. discuss at least one biological and one geographical reason for this fact. please include resources. thank you

    © BrainMass Inc. brainmass.com October 10, 2019, 8:11 am ad1c9bdddf
    https://brainmass.com/biology/viruses/vaccine-development-612329

    Solution Preview

    http://www.bio.miami.edu/tom/courses/bil160/bil160goods/11_protists.html

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238332/

    biological and geographical issues for vaccine development for diseases caused by protists (e.g. malaria, chagas' disease) have been much less successful than for bacterial or viral diseases. discuss at least one reason for this fact. please include resources. thank you

    In reference to the biological and geographical issues that prevent breakthroughs in vaccine progress for protists in comparison to bacterial or viral diseases, the issue stems from the fact that according to recent research that has identified evidence that "protists" have a far greater degree of diversity than any other eukaryotic kingdom, which makes it extremely difficult to develop the necessary vaccine to treat chronic diseases. This problem is juxtaposed by the fact that this diversity is bolstered by a phenomenon that is unique to protists, which is the fact that biologists have discovered that many "protists" are far more closely related to members of other eukaryotic kingdoms than to their own kingdom. This is counter to the norm as by definition, members of a living kingdom should be more like one another as opposed to resembling members of other kingdoms. Therefore, researchers are forced to reclassify protists, which has resulted in a historical classification that ...

    Solution Summary

    The expert examines vaccine development. At least one biological and one geographical reason for the fact are determined.

    $2.19